美股新聞 標題聯播 · 近 24 小時 305 則 · 28 個來源 · 最新 9/20 06:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · OGN近 30 天 5 則 · 第 1 / 1 頁
- PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor
- Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device
- Orogen Royalties Acquires Two Gold Projects in Southwest Utah
- Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer
- National Can-RISE Study to Help Close Critical Gaps in Menopause Research
- Orogen Royalties Announces Results of the 2026 Annual General Meeting
- Priori Expands Client Advisory Board with New Members from Fortune 500 Corporate Legal Departments
- Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability
- Orogen Royalties Acquires the Two Peaks Project in Arizona
- Compared to Estimates, Organon (OGN) Q2 Earnings: A Look at Key Metrics
- Organon (OGN) Lags Q2 Earnings Estimates
- Organon Announces Quarterly Dividend
- Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
- New Analysis of Phase 3 Pooled Data for Organon’s VTAMA® (tapinarof) cream, 1%, Demonstrates Early, Consistent Improvements in Atopic Dermatitis Patients Across Pediatric Age Groups and in Adults1
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。